Authors:
MAKINEN K
HAKALA T
LIPPONEN P
ALHAVA E
ESKELINEN M
Citation: K. Makinen et al., CLINICAL CONTRIBUTION OF BCL-2, P53 AND KI-67 PROTEINS IN PANCREATIC DUCTAL ADENOCARCINOMA, Anticancer research, 18(1B), 1998, pp. 615-618
Authors:
SHAPIRO R
VIVAS C
SCANTLEBURY VP
JORDAN ML
GRITSCH HA
NEUGARTEN J
MCCAULEY J
RANDHAWA P
IRISH W
FUNG JJ
HAKALA T
SIMMONS RL
STARZL TE
Citation: R. Shapiro et al., SUBOPTIMAL KIDNEY DONORS - THE EXPERIENCE WITH TACROLIMUS-BASED IMMUNOSUPPRESSION, Transplantation, 62(9), 1996, pp. 1242-1246
Citation: L. Salminen et al., CORNEAL VASCULARIZATION AND OPACIFICATION DURING LONG-TERM USE OF DIPIVEFRIN, Journal of ocular pharmacology and therapeutics, 11(1), 1995, pp. 37-40
Citation: T. Hakala et A. Riitahuhta, CASE-STUDY OF TRIBOLOGY AT TAMPERE-UNIVERSITY-OF-TECHNOLOGY - PERCUSSIVE ROCK DRILLING TUBE, Wear, 181, 1995, pp. 840-843
Authors:
LAHDEAHO ML
LEHTINEN T
AINE R
HAKALA T
LEHTINEN M
Citation: Ml. Lahdeaho et al., ANTIBODY-RESPONSE TO ADENOVIRUS E1B-DERIVED SYNTHETIC PEPTIDES AND SERUM LEVELS OF P53 IN PATIENTS WITH GASTROINTESTINAL AND OTHER MALIGNANT-LYMPHOMAS, Journal of medical virology, 43(4), 1994, pp. 393-396
Authors:
LEHTINEN T
AINE R
KELLOKUMPULEHTINEN P
HAKALA T
LEHTINEN M
Citation: T. Lehtinen et al., EVALUATION OF PLASMA-LEVELS OF THYMIDINE KINASE AND MUTATED P53 IN 81PATIENTS WITH NEWLY-DIAGNOSED MALIGNANT-LYMPHOMA, Acta oncologica, 32(7-8), 1993, pp. 779-781
Authors:
KOISTINEN R
ANGERVO M
LEINONEN P
HAKALA T
SEPPALA M
Citation: R. Koistinen et al., PHOSPHORYLATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 INCREASES IN HUMAN AMNIOTIC-FLUID AND DECIDUA FROM EARLY TO LATE PREGNANCY, Clinica chimica acta, 215(2), 1993, pp. 189-199